Hepion PharmaceuticalsHEPA
13F holders, Q2 2025 (June 30)3holders −13
2new positions
16sold out
$0.08avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings, down 13 from Q1 2025. 2 opened new positions and 16 sold out. The largest holders were XTX Topco Ltd ($1K), Barclays PLC ($0) and Osaic Holdings, Inc. ($0).
- Company
- Hepion Pharmaceuticals Inc.
- CUSIP
- 426897401
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 16 | $420K |
All 13F filers, Q1 2025 → Q2 2025: 17,363 shares bought and 976,365 shares sold, net −959,002 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| XTX Topco Ltd | 0.00% | New | 17,361 | $1K |
| Barclays PLC | 0.00% | New | 1 | $0 |
| Osaic Holdings, Inc. | 0.00% | Add +50.0% | 3 | $0 |
"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.